Sikora K, Warenius H
Med Oncol Tumor Pharmacother. 1986;3(1):5-9. doi: 10.1007/BF02934569.
We have examined the serological response in immunosuppressed mice bearing xenografts of the human colorectal carcinoma line HT29. The sera of such animals contain antibodies which bind to HT29 cell membrane components. This antibody activity was not completely absorbed by either human lymphocytes or red blood cells suggesting that at least part of this activity is directed against tumour-associated antigens. By fusing the spleens from tumour-bearing animals to an established myeloma line we were able to produce 34 monoclonal antibodies which bound to HT29 cells. The specificity of these antibodies in binding assays against membrane preparations from a variety of normal and malignant tissues and cell lines was determined. Twenty-seven bound to components present on both normal and malignant human cell membranes; 4 to tumour membranes only, whilst 3 bound specifically to membranes prepared from colorectal carcinoma tissue or cell lines. Thus despite immunosuppression the xenograft-bearing mouse was able to recognise a number of antigens present on the tumour surface.
我们检测了携带人结肠直肠癌HT29细胞系异种移植瘤的免疫抑制小鼠的血清学反应。这类动物的血清中含有能与人HT29细胞膜成分结合的抗体。人淋巴细胞或红细胞都不能完全吸收这种抗体活性,这表明该活性至少部分是针对肿瘤相关抗原的。通过将荷瘤动物的脾脏与一种已建立的骨髓瘤细胞系融合,我们获得了34种能与人HT29细胞结合的单克隆抗体。测定了这些抗体在针对多种正常和恶性组织及细胞系膜制剂的结合试验中的特异性。27种抗体与正常和恶性人细胞膜上都存在的成分结合;4种仅与肿瘤细胞膜结合,而3种则特异性地与人结肠直肠癌组织或细胞系制备的膜结合。因此,尽管处于免疫抑制状态,携带异种移植瘤的小鼠仍能够识别肿瘤表面存在的多种抗原。